| Aktsiad | 585,25 B | — | KO KoAct | 0,00 | Tervishoiu | | 3.8.2023 | 21 596,80 | 8,05 | 37,04 |
TE | Aktsiad | 241,5 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 7.10.2020 | 6651,11 | 6,03 | 51,44 |
KO | Aktsiad | 202,5 B | — | KO KODEX | 0,45 | Tervishoiu | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 7647,65 | 5,44 | 37,93 |
TE | Aktsiad | 127,8 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KRX Healthcare - KRW | 18.7.2011 | 34 195,67 | 4,63 | 39,62 |
TE | Aktsiad | 101,1 B | — | TE Tiger ETF | 0,30 | Tervishoiu | NASDAQ / Biotechnology | 27.8.2014 | 33 844,65 | 4,88 | 21,01 |
| Aktsiad | 71,7 B | — | KR KB RISE | 0,00 | Tervishoiu | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 679,68 | 9,56 | 68,04 |
KO | Aktsiad | 66,8 B | — | KO KODEX | 0,09 | Tervishoiu | KRX Healthcare - KRW | 28.3.2017 | 15 535,55 | 4,63 | 39,65 |
KO | Aktsiad | 61,4 B | — | KO KODEX | 0,25 | Tervishoiu | S&P Health Care Select Sector | 21.3.2023 | 13 619,17 | 4,86 | 22,50 |
SP | Aktsiad | 47,55 B | 9,06 M | SP SPDR | 0,08 | Tervishoiu | S&P Health Care Select Sector | 16.12.1998 | 179,69 | 4,86 | 22,63 |
TE | Aktsiad | 47,1 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 15.12.2016 | 10 624,90 | 10,44 | 59,10 |
TE | Aktsiad | 44,5 B | — | TE Tiger ETF | 0,45 | Tervishoiu | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 059,99 | 7,96 | 17,83 |
KO | Aktsiad | 42,66 B | — | KO KODEX | 0,45 | Tervishoiu | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 794,98 | 5,08 | 12,43 |
TE | Aktsiad | 41,9 B | — | TE Tiger ETF | 0,49 | Tervishoiu | Solactive China Biotech Index | 8.12.2020 | 7760,45 | 4,03 | 28,69 |
TE | Aktsiad | 30,3 B | — | TE Tiger ETF | 0,40 | Tervishoiu | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 1.7.2016 | 26 434,07 | 0,00 | 0,00 |
| Aktsiad | 28,45 B | — | HW Hwabao | 0,60 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
TE | Aktsiad | 28,1 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 17 982,54 | 2,91 | 30,55 |
KO | Aktsiad | 22,6 B | — | KO KODEX | 0,25 | Tervishoiu | S&P Biotechnology Select Industry | 31.10.2013 | 42 570,51 | 0,00 | 0,00 |
VA | etf_assetclass_Sector Equity | 21,8 B | 236 249 | VA Vanguard | 0,09 | Tervishoiu | MSCI US IMI 25/50 Health Care | 26.1.2004 | 332,22 | 5,01 | 23,09 |
EF | Aktsiad | 17,42 B | — | EF E Fund | 0,00 | Tervishoiu | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,40 | 26,67 |
NH | Aktsiad | 16 B | — | NH NH-Amundi | 0,00 | Tervishoiu | | 26.11.2024 | 14 892,57 | 5,00 | 44,18 |
| Aktsiad | 14,21 B | — | KO KoAct | 0,50 | Tervishoiu | | 11.11.2025 | 10 338,06 | 5,59 | 22,65 |
| Aktsiad | 12,6 B | — | KR KB RISE | 0,00 | Tervishoiu | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 16 773,64 | 4,73 | 37,18 |
IS | Aktsiad | 10,86 B | 1,61 M | IS iShares | 0,44 | Tervishoiu | NYSE Biotechnology (TR) | 5.2.2001 | 210,52 | 5,10 | 21,90 |
SP | Aktsiad | 10,42 B | 9,16 M | SP SPDR | 0,35 | Tervishoiu | S&P Biotechnology Select Industry | 31.1.2006 | 153,17 | 5,08 | 0,00 |
| Aktsiad | 9,16 B | — | AC ACE | 0,30 | Tervishoiu | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 860,55 | 7,21 | 21,79 |
KI | Aktsiad | 8,41 B | — | KI Kiwoom | 0,49 | Tervishoiu | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 12 779,55 | 0,00 | 0,00 |
| Aktsiad | 8,18 B | — | AC ACE | 0,45 | Tervishoiu | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 381,65 | 3,60 | 21,75 |
| Aktsiad | 7,94 B | — | KO KoAct | 0,00 | Tervishoiu | | 27.1.2026 | 10 133,67 | 4,34 | 29,64 |
| Aktsiad | 6,85 B | — | KO KoAct | 0,50 | Tervishoiu | | 3.9.2024 | 12 841,88 | 4,21 | 17,95 |
BO | Aktsiad | 6,66 B | — | BO Bosera | 0,65 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,61 | 2,75 | 12,80 |
CH | Aktsiad | 6,37 B | — | CH ChinaAMC | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,82 | 3,00 | 21,32 |
KI | Aktsiad | 5,93 B | — | KI Kiwoom | 0,49 | Tervishoiu | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 652,44 | 4,37 | 17,87 |
TE | Aktsiad | 5,7 B | — | TE Tiger ETF | 0,50 | Tervishoiu | FnGuide Medical Device Index - KRX - Benchmark TR Net | 8.11.2018 | 12 355,27 | 2,77 | 23,45 |
| Aktsiad | 5,69 B | — | MA Maxwealth | 0,60 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
| Aktsiad | 5,44 B | — | NI Nippon | 0,19 | Tervishoiu | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aktsiad | 5,44 B | — | NF NEXT FUNDS | 0,32 | Tervishoiu | | 21.3.2008 | 33 088,93 | 1,86 | 21,64 |
| Aktsiad | 5,15 B | — | KR KB RISE | 0,35 | Tervishoiu | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9602,93 | 7,72 | 19,09 |
TE | Aktsiad | 4,91 B | — | TE Tiger ETF | 0,40 | Tervishoiu | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0,00 | 0,00 |
IN | Aktsiad | 4,86 B | — | IN Invesco | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,62 |
IC | Aktsiad | 4,74 B | — | IC ICBC | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,24 | 0,00 | 0,00 |
IS | Aktsiad | 4,6 B | 246 342 | IS iShares | 0,38 | Tervishoiu | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 13.11.2001 | 108,99 | 4,19 | 21,81 |
IS | Aktsiad | 4,48 B | 725 463 | IS iShares | 0,37 | Tervishoiu | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 75,49 | 4,86 | 22,76 |
EF | Aktsiad | 4,02 B | — | EF E Fund | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0,00 | 0,00 |
XT | Aktsiad | 3,84 B | 57 947 | XT Xtrackers | 0,25 | Tervishoiu | MSCI World Index / Health Care -SEC | 4.3.2016 | 58,09 | 4,44 | 21,81 |
GU | Aktsiad | 3,73 B | — | GU Guotai | 0,60 | Tervishoiu | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,00 | 0,00 | 0,00 |
FI | Aktsiad | 3,54 B | 241 890 | FI Fidelity | 0,08 | Tervishoiu | MSCI US IMI 25/50 Health Care | 21.10.2013 | 86,19 | 4,77 | 22,64 |
IS | Aktsiad | 3,46 B | 2,84 M | IS iShares | 0,37 | Tervishoiu | DJ US Select / Medical Equipment | 1.5.2006 | 54,23 | 3,79 | 29,41 |
IS | Aktsiad | 3,4 B | 548 259 | IS iShares | 0,15 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 14,54 | 4,86 | 22,63 |
FU | Aktsiad | 3,15 B | — | FU Fullgoal | 0,60 | Tervishoiu | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 2,99 B | 75 620 | FT First Trust | 0,55 | Tervishoiu | NYSE Arca Biotechnology Index | 19.6.2006 | 271,82 | 3,45 | 22,71 |
NH | Aktsiad | 2,73 B | — | NH NH-Amundi | 0,45 | Tervishoiu | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,46 B | — | HW Hwabao | 0,00 | Tervishoiu | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 B | 0,00 | 0,00 |
| Aktsiad | 2,31 B | — | IP ICICI Prudential IETF | 0,13 | Tervishoiu | Nifty Healthcare Index - INR - Benchmark TR Gross | 18.5.2021 | 160,98 | 5,10 | 34,66 |
GU | Aktsiad | 2,3 B | — | GU Guotai | 0,60 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,90 |
CH | Aktsiad | 2,21 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
CH | Aktsiad | 2,21 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
HA | Aktsiad | 2,14 B | 346 544 | HA Harvest | 0,85 | Tervishoiu | | 18.12.2014 | 7,59 | 5,01 | 23,83 |
PA | Aktsiad | 1,82 B | — | PA Ping An | 0,60 | Tervishoiu | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
EF | Aktsiad | 1,62 B | — | EF E Fund | 0,20 | Tervishoiu | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,50 | 20,25 |
IS | Aktsiad | 1,61 B | 22 123 | IS iShares | 0,41 | Tervishoiu | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 152,88 | 0,00 | 0,00 |
IS | Aktsiad | 1,56 B | 258 893 | IS iShares | 0,37 | Tervishoiu | DJ US Select / Pharmaceutical | 1.5.2006 | 103,34 | 4,59 | 21,41 |
IS | Aktsiad | 1,56 B | 118 526 | IS iShares | 0,40 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 11,05 | 3,82 | 20,92 |
AM | Aktsiad | 1,49 B | — | AM Amundi | 0,50 | Tervishoiu | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
EF | Aktsiad | 1,45 B | — | EF E Fund | 0,20 | Tervishoiu | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,40 | 4,40 | 29,55 |
EF | Aktsiad | 1,44 B | — | EF E Fund | 0,20 | Tervishoiu | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,50 | 2,80 | 29,20 |
IS | Aktsiad | 1,4 B | 577 004 | IS iShares | 0,37 | Tervishoiu | DJ US Select / Health Care Providers | 1.5.2006 | 60,28 | 2,30 | 16,34 |
CA | Aktsiad | 1,39 B | — | CA Cathay | 1,05 | Tervishoiu | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,22 | 3,39 | 17,66 |
IS | Aktsiad | 1,39 B | 99 574 | IS iShares | 0,40 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,84 | 3,82 | 20,92 |
EF | Aktsiad | 1,32 B | — | EF E Fund | 0,20 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,68 | 3,14 | 28,62 |
GU | Aktsiad | 1,31 B | — | GU Guotai | 0,60 | Tervishoiu | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,95 | 0,00 | 0,00 |
IS | Aktsiad | 1,2 B | 232 868 | IS iShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 19.10.2017 | 10,36 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 1,14 B | 59 029 | FT First Trust | 0,61 | Tervishoiu | StrataQuant Health Care Index | 8.5.2007 | 135,09 | 3,02 | 17,23 |
AM | Aktsiad | 1,14 B | 126 | AM Amundi | 0,30 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 629,55 | 7,37 | 31,30 |
FT | etf_assetclass_Sector Equity | 1,13 B | 487 916 | FT First Trust | 0,60 | Tervishoiu | Nasdaq US Smart Pharmaceuticals Index | 20.9.2016 | 42,69 | 4,73 | 18,68 |
VA | Aktsiad | 1,13 B | 293 612 | VA VanEck | 0,36 | Tervishoiu | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 116,28 | 4,92 | 18,95 |
HA | Aktsiad | 1,13 B | — | HA Harvest | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,91 | 0,00 | 0,00 |
PB | Aktsiad | 1,11 B | 125 547 | PB Portfolio Building Block ETFs | 0,13 | Tervishoiu | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 29,73 | 4,93 | 20,32 |
XT | Aktsiad | 1,02 B | 7337 | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 71,69 | 5,07 | 22,81 |
AM | Aktsiad | 1,01 B | 702 | AM Amundi | 0,30 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 559,85 | 7,68 | 29,88 |
GX | Aktsiad | 977,46 M | — | GX Global X | 0,59 | Tervishoiu | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1739,46 | 1,90 | 19,17 |
AM | Aktsiad | 965,76 M | 278 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 199,48 | 2,98 | 20,61 |
AM | Aktsiad | 965,76 M | 11 066 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 157,10 | 2,85 | 19,76 |
IN | Aktsiad | 956,4 M | 164 483 | IN Invesco | 0,40 | Tervishoiu | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 39,36 | 3,04 | 19,91 |
CS | Aktsiad | 926,44 M | — | CS CSOP | 1,50 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,75 | 3,33 | 23,96 |
| Aktsiad | 897,71 M | — | WA Wanjia | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,62 | 3,45 | 24,62 |
AM | Aktsiad | 809,91 M | 2291 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 131,75 | 2,85 | 19,76 |
XT | Aktsiad | 765,44 M | 11 505 | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 53,54 | 5,07 | 22,81 |
IS | Aktsiad | 757,84 M | 87 433 | IS iShares | 0,18 | Tervishoiu | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 6,21 | 3,73 | 19,22 |
IS | Aktsiad | 751,42 M | 63 598 | IS iShares | 0,18 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,66 | 4,16 | 22,04 |
SP | Aktsiad | 747,96 M | 13 570 | SP SPDR | 0,30 | Tervishoiu | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 28.2.2009 | 75,15 | 4,44 | 21,81 |
| Aktsiad | 746,7 M | — | AB Aditya Birla Sun Life | 0,09 | Tervishoiu | Nifty Healthcare Index - INR - Benchmark TR Gross | 19.10.2021 | 16,14 | 5,10 | 34,66 |
CA | Aktsiad | 721,53 M | — | CA Cathay | 0,41 | Tervishoiu | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,05 | 0,00 | 0,00 |
IS | Aktsiad | 700,32 M | 6590 | IS iShares | 0,46 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 117,22 | 3,63 | 19,15 |
GX | Aktsiad | 673,42 M | — | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 24.7.2019 | 70,15 | 4,18 | 30,21 |
GX | Aktsiad | 665,49 M | 25 380 | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 24.7.2019 | 71,17 | 4,18 | 30,21 |
DI | etf_assetclass_Leveraged/Inverse | 642,71 M | 443 322 | DI Direxion | 0,96 | Tervishoiu | S&P Biotechnology Select Industry | 28.5.2015 | 235,90 | 0,00 | 0,00 |
CS | Aktsiad | 615,18 M | — | CS China Southern | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,10 | 2,98 | 21,35 |
SP | Aktsiad | 615,16 M | 1741 | SP SPDR | 0,18 | Tervishoiu | MSCI Europe Health Care Index - EUR | 30.9.2001 | 236,92 | 3,73 | 19,22 |
IS | Aktsiad | 589,27 M | 6595 | IS iShares | 0,66 | Tervishoiu | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 78,57 | 0,00 | 0,00 |
IN | Aktsiad | 586,67 M | 36 607 | IN Invesco | 0,40 | Tervishoiu | NASDAQ / Biotechnology | 6.11.2014 | 74,63 | 4,94 | 21,49 |